Rationale: Alveolar type II cell transplantation has been proposed as a cell therapy for the treatment of idiopathic pulmonary fibrosis. Its long-term benefits include the repair of lung fibrosis, but its success partly depends on the restoration of lung homeostasis.
Introduction
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and fatal disease of unknown etiology. The median survival time is 3 to 5 years from the time of diagnosis (1) . At present there is no effective pharmacological therapy for IPF, although some new treatment approaches have shown a degree of efficacy (2) (3) .
It has been suggested that chronic injury and apoptosis of alveolar type II cells (ATII) underlie the development and progression of IPF (4) (5) , ultimately resulting in fibroblast proliferation, increased extra-cellular matrix deposition and loss of alveolar structure (6) . In normal physiological conditions, the renewal of alveolar epithelial cells occurs through the specific proliferation and differentiation of ATII into alveolar type I cells (ATI). In pulmonary fibrosis, however, the ATII and ATI die, compromising the normal regeneration process and leading to an aberrant wound healing response (4) (5) (6) . Therefore, any strategy seeking to attenuate or reverse pulmonary fibrosis should involve the maintenance of alveolar epithelium integrity. In this respect, our group has previously demonstrated that intratracheal transplantation of ATII is able to reverse bleomycin (BLM)-induced pulmonary fibrosis in a rat model (7) .
ATII have a great number of complementary physiological functions, besides replacing alveolar epithelial cells (8) . ATII are the only cells to synthesize, secrete and recycle the pulmonary surfactant needed to prevent alveolar collapse, by reducing the surface tension across the air-liquid interface of the alveoli (9) . The presence of lung surfactant also helps to maintain the lung's gas exchange area and prevents the formation of edema. The loss of ATII during the development of pulmonary fibrosis contributes to alveolar collapse caused by a lack of surfactant (10) .
Pulmonary surfactant is a complex molecule composed of 90% lipids and 10% proteins.
There are four surfactant proteins (SP-A, SP-B, SP-C and SP-D) and they play pivotal roles in the alveolar homeostasis and host defence.
Several studies have shown that changes in pulmonary surfactant could cause interstitial lung diseases in both children and adults (11) (12) (13) (14) (15) (16) . Moreover, patients with IPF have presented a down-regulation of SP-B and SP-C levels during the fibro-proliferative period (11) (12) (13) . Mutations in the gene encoding SP-C have been identified in both familial and sporadic cases of IPF (15) , while transgenic mice deficient in SP-C or SP-D have shown greater susceptibility to BLM, indicating that a lack of SP-C or SP-D predisposes to the development of lung fibrosis (17, 18) . Lastly, patients with IPF have also presented alterations in the surfactant protein processing due to endoplasmic reticulum stress (19) . All these findings show that surfactant alterations are involved in the development of pulmonary fibrosis and may be partly responsible for alveolar collapse, ventilation-perfusion mismatching and/or hypoxemia (20) .
In this study we have focused on changes in pulmonary surfactant protein levels during BLMinduced lung fibrosis in rats and the ability of ATII transplantation to restore these surfactant protein levels.
Methods

Animals.
Sprague-Dawley rats, weighting 200-225 g at the beginning of the experiment, were used, in accordance with the European Community (Directive 86/609/EEC) and Spanish guidelines for experimental animals and it was approved by the institutional committees of animal care and research of University of Barcelona.
Bleomycin-induced lung fibrosis. Lung fibrosis was induced by intratracheal instillation of a single dose of BLM (2.5 U/kg) (Sigma, USA) dissolved in 400 l of sterile saline under isofluorane anesthesia (7) . Control animals received the same volume of saline. The animal body weights were recorded every 2 days during the course of the experiment.
Isolation of Alveolar Type II Cells. ATII were isolated from healthy donor animals. For more details, see the online data supplement.
Cell yield, purity and characterization of freshly isolated ATII were established by the presence of intracellular alkaline phosphatase (Sigma, USA) (Fig. 1A) , lamellar bodies and microvilli at the electron microscope level (Fig. 1B) by immnunofluorescence (Fig 1C) , realtime PCR (Fig 1D) and by flow citomety (Fig 1E) . For more details, see the online data supplement.
Isolation of Alveolar
Macrophages. An additional alveolar macrophage (AM) transplantation group was established,using another unrelated cell type, to evaluate whether the beneficial effect was specific to ATII transplantation. AM were isolated from healthy donor animals. For more details, see the online data supplement.
Cell yield, purity and characterization of freshly isolated AM were evaluated in cytospin preparations, after staining with the Diff-Quick kit (Diagnostics Grifoll S.A, Spain). Over 95% (n=8) of brochoalveolar lavage cells were macrophages (Fig. 1F ). AM were also characterized by transmission electron microscopy ( Fig 1G) . 
Statistical analysis. Data are expressed as mean ± SEM values with 95% confidence intervals (CI). Statistical analysis was carried out by analysis of variance (ANOVA) followed
by appropriate post hoc tests, including the Newman-Keuls test when differences were significant (GraphPad Software Inc, USA). A p value of <0.05 was considered significant.
Results
At the end of cell isolation, purity of the ATII cells was 86 ± 6 %, as shown by positive staining with alkaline phosphatase or with the immunohistochemstry for p180 (Fig 1A, 1C) .
Results of real-time PCR showed a higher expression of SP-B and SP-C in the isolated ATII compared to the expression of these two surfactant proteins in the isolated AM (Fig 1D) .
Finally, the percentage of p-180 positive cells was determined by flow cytometry in three independent experiments. The purity of isolated ATII measured by flow cytometry was 81.56 ± 3.26 % (Fig. 1E ).
BLM instillation caused a marked loss in body weight, which was normally recovered later on. The animals subjected to ATII transplantation gained weight more quickly than those in 7 the BLM, BLM+AM and BLM+SP groups ( Fig. 2A ). This indicates that ATII transplantation was the only therapy that enhanced the animals' health. Moreover, BLM caused an increase in lung weight, owing to the inflammatory and fibrotic component (7) . Lung weight significantly decreased only in the ATII transplanted group after BLM instillation, compared with the BLM, BLM+AM and BLM+SP groups (Fig. 2B) . The amount of hydroxyproline -a modified amino acid specific to collagen -was assessed to determine how ATII transplantation could alter the course of BLM-induced lung injury. BLM, BLM+AM and BLM+SP lungs showed a significant increase in the amount of lung hydroxyproline when compared with saline control groups (Fig. 2C) . In contrast, hydroxyproline levels were significantly reduced in the BLM+ATII transplanted group (Fig. 2C) . These results confirm that ATII transplantation induces a reduction in collagen deposition and, consequently, in the fibrotic response.
Since the control groups were found to present equivalent data (data not shown) for histology, immunofluorescence, mRNA and Western blot, the results are matched in a single control group for graphic tractability.
The engraftment of the transplanted cells in the recipient animals was assessed by fluorescent microscopy. In the BLM + AM group only a few AM red PKH26 positives were observed in some areas of the lung sections (Fig. 3A) . In contrast, in the BLM+ATII numerous ATII red PKH26 positives were observed in the transplanted animals, mainly in areas of fibrosis (Fig. 3A) . The percentage of engrafted cells in the transplanted animals after one week of the infusion was 14 ± 9 %.
To confirm the presence of fibrotic lesions, lung serial sections were stained with Masson trichrome and examined by light microscopy (Fig. 3B) . Lung tissue sections from control rats showed no evidence of inflammation or epithelial damage but, as expected, lung tissue sections from rats with BLM-induced fibrosis showed marked peribronchiolar and interstitial infiltration, with inflammatory cells, extensive cellular thickening of interalveolar septa, interstitial edema, an increase in interstitial cells with a fibroblastic appearance and an excess of collagen deposition (Fig. 3B) . Similar results were obtained in the lung tissues from 8 the BLM+AM and BLM+SP groups (Fig. 3B) . However, although multifocal parenchymal lesions were still present in the BLM+ATII group, the organized fibroblast foci were smaller and considerably fewer than those observed in the BLM, BLM+AM and BLM+SP groups (Fig.   3B) . Moreover, the reduction in parenchymal lesions was evidenced by large areas of undamaged tissue with normal alveolar architecture (Fig. 3B) .
To determine one of the mechanisms involved in the beneficial effect of ATII transplantation, we studied the changes in the expression and release of pulmonary surfactant proteins (Fig.   4 and 5) . Quantitative real-time PCR analysis (Fig. 4) revealed a significant decrease in the expression of all the pulmonary surfactant proteins in the BLM group, compared to the control group. ATII transplantation was the only therapy that showed a significant increase in the expression of all the pulmonary surfactant proteins, compared with the BLM group (Fig.   4 ). Since macrophage transplantation and surfactant administration did not induce changes in the expression of the surfactant proteins, its quantification was determined only in the BLM+ATII group. Alterations in protein expression corresponding to mRNA changes were assessed by Western blot analysis for SP-B, SP-C and SP-D. Surfactant protein levels were significantly decreased in the BLM group, compared with the control group (Fig. 5) . In contrast, the levels of SP-B, SP-C and SP-D were significantly increased in the BLM+ATII group compared to the BLM group, although SP-C and SP-D did not achieve the control levels, while SP-B was increased to levels above those of the control group, albeit without any significant difference (Fig. 5) . All in all, these results indicate the re-establishment of pulmonary surfactant protein levels.
To further examine the increase in the surfactant levels caused by ATII transplantation in BLM-induced pulmonary fibrosis, lung serial sections were immunostained, using an antibody anti-p180 lamellar body (Fig. 6) , and then examined by fluorescent microscopy.
Lung tissue sections from BLM, BLM+AM and BLM+SP showed only a weak staining for the anti-p180 lamellar body (Fig. 6) . In contrast, the BLM+ATII group was once again the only group to show a marked increase in positive cells for the p180 lamellar body. Furthermore, some of the positive anti-p180 cells were donor cells as they were also positives for the red PKH26 marker (Fig. 6) ; in addition, some of these cells were located in the corner of the alveolus, the usual site of ATII (Fig 6) , indicating that after ATII transplantation takes place the repopulation of the pulmonary epithelium and also the restoration of the pulmonary architecture.
Discussion
Previous studies performed by our group have demonstrated that ATII transplantation produces several beneficial effects in an animal model of BLM-induced lung fibrosis, leading ultimately to the reversal of disease (7). Since ATII are the cells exclusively responsible for the synthesis and release of some pulmonary surfactant proteins and are specifically involved in the regulation of the surfactant pool, we hypothesized that depletion of ATII during pulmonary fibrosis compromises the capacity to regulate normal levels of pulmonary surfactant, further amplifying the fibrogenic process.
The present study demonstrates that some of the beneficial effects observed after ATII transplantation may be explained by the restoration of surfactant levels. Furthermore, ATII transplantation was able to increase the levels of all four surfactant proteins. In contrast, neither AM transplantation nor exogenous surfactant administration led to any recovery in the expression of surfactant proteins, or in body weight, nor a decrease in collagen deposition or an improvement in parenchymal lesions. These results confirm that ATII transplantation has a specific role in the resolution of disrupted alveolar surfaces, partly by inducing the restoration of surfactant levels.
It is known that ATII death is a key component in the progression of pulmonary fibrosis (21).
ATII synthesizes all four surfactant proteins, and SP-C is the only surfactant protein Altogether, these factors indicate that alterations in the surfactant system during the development of pulmonary fibrosis may amplify the fibrogenic processes.
The most important result of this study is that only the ATII transplantation induced the restoration of the surfactant protein pool. In contrast, neither macrophage transplantation nor surfactant administration were able to recover the expression levels of any surfactant proteins after BLM administration. Furthermore, ATII transplantation was able to increase the release of all surfactant proteins. This recovery of surfactant protein suggests not only the expression and release of new protein but also the reestablishment of the recycling capacity intrinsic to healthy transplanted ATII. Nevertheless, we observed that positive cells for SP-C were not only transplanted ATII but also own ATII cells, indicating that after ATII transplantation takes place the recovery of the own pulmonary epithelium cell functionality.
This means that the restoration of the surfactant system could be attributed not only to the new donor cells but also to the recruitment of own epithelial cells thus amplifying the beneficial effect of ATII transplantation. The functional surfactant synthesized and released 11 will keep the alveoli clear of liquid, while also maintaining a thin fluid film that will enhance breathing capacity. These findings were only induced in the ATII transplantation group. In contrast, surfactant administration was not able to reestablish the surfactant system, increasing the importance of healthy ATII in opening up collapsed but still functional alveoli.
In this regard, the immunofluorescence studies confirm all these results, as the lung of animals transplanted with ATII showed extensive restoration of the pulmonary architecture, together with a clear increase in the number of surfactant positive cells.
In conclusion, this study shows that one of the mechanisms involved in the beneficial effect of ATII transplantation is the restoration of the lung surfactant protein levels, released by themselves or trough the recovery of the own pulmonary epithelium cell functionality needed for proper respiratory function. To perform the phospatase alkaline kit and the immunochemistry assay isolated ATII were cytocentrifuged (Cytospin 3 centrifuge Shandon Scientific Ltd, Grupo Taper, Spain), allowed to dry in air for 15 min at RT. The phosphatase staining was conducted according to the manufacturer's protocol for alkaline phosphatase.
Legends
Immunochemistry analysis were done in ATII cytospins, the cells were labelled using an antibody against p180 lamellar body (Abcam, UK), specific to surfactant lamellar bodies, and Isolation of Alveolar Macrophage. Fresh AM were isolated from healthy donor animals by performing a bronchoalveolar lavage. Bronchoalveolar lavage was undertaken by washing the lung five times with 10 ml saline aliquots via a tracheal cannula and centrifuging (300 x g, 20 min, 4 ºC). The AM viability after isolation was assessed by Trypan Blue and proved to be >95%.
Transmission electron microscopy. The ATII and AM characterization was evaluated by transmission electron microscopy. The cells were fixed in 2.5% glutaraldehyde in 0.1 mol/l phosphate buffer (pH 7.4) for at least 2 h at 4 ºC. The cells were secondarily fixed in 1% osmium tetroxide and 0.8% potassium ferrocyanide for 1 h at 4 ºC. After 3 washes with cold double distilled water, the sample was dehydrated with an ascending concentration of acetone (30%, 50%, 70%, 95%, and 100%), and three changes of 100% acetone. They were then embedded in Spurr resin and polymerized at 60 °C. The embedded blocks were sectioned using a diamond knife (Diatome) on a Leica Ultracut UCT (Leica Microsystems, Deerfield, IL). Ultrathin sections were placed on copper grids and stained with ranyl acetate and lead citrate before examination under a JEM 1010 (Jeol Ltd., Tokio, Japan) equipped with a Gatan/BioScan digital camera (Gatan Inc., Pleasanton, CA).
Cell Engraftment. After cell isolation the ATII and the AM were labeled by the PKH26 Red Hidroxyproline content. Lung hydroxyproline content was measured as an indicator of collagen deposition, following the method outlined by Woessner (E1). Samples were homogenized and then hydrolyzed in 6 M HCl, and the hydrolysate was then neutralized with
